Using this strategy for targeted delivery of 177Lu to HER2-expressing xenografts, they demonstrated that a single administration of 177Lu-CHX-A′′-DTPA-ABD-(ZHER2:342)2 completely prevented the formation of tumours in mice. This evidence concerns the gene ERBB2 and neoplasm.